{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:07:23Z","timestamp":1793160443060,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Observational studies suggest that direct contact from healthcare to at-risk relatives may increase genetic counselling (GC) uptake as compared to family-mediated risk disclosure, but randomised controlled trials (RCTs) are lacking. This study assessed whether the offer of direct letters to relatives at risk of hereditary breast and ovarian cancer (HBOC) or Lynch syndrome increases GC uptake compared to family-mediated communication alone. Between 2020 and 2023, probands were randomly assigned to family-mediated disclosure (control) or family-mediated disclosure plus the offer of sending direct letters to at-risk relatives (intervention). The primary outcome was GC uptake within 12 months, measured as the proportion of eligible relatives at risk contacting a Swedish cancer genetics clinic. In total, 165 families (median: 4 eligible relatives, range: 1\u201326) were randomised to control (<jats:italic>n<\/jats:italic>\u2009=\u200979) or intervention (<jats:italic>n<\/jats:italic>\u2009=\u200986). GC uptake was 67% in controls and 71% in the intervention group (<jats:italic>P<\/jats:italic>\u2009=\u20090.23). After adjusting for predefined variables and covariates, there was still no significant difference between groups (OR: 1.24, CI: 0.79\u20131.95, <jats:italic>P<\/jats:italic>\u2009=\u20090.34). Distant relatives had lower uptake than first-degree relatives (OR: 0.27, CI: 0.18\u20130.40, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), while female relatives had higher uptake than males (OR: 2.17, CI: 1.50\u20133.12, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). This is the largest RCT so far investigating direct letters to relatives. GC uptake was high in both groups, and the intervention of direct letters did not show superiority over family-mediated communication alone. Direct letters to relatives may complement family-mediated disclosure in certain situations, but should not be implemented as a general procedure in cancer genetics practices.<\/jats:p>","DOI":"10.1038\/s41431-025-01922-w","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T20:47:25Z","timestamp":1753994845000},"page":"1359-1367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Direct letters to relatives at risk of hereditary cancer\u2014a randomised trial on healthcare-assisted versus family-mediated risk disclosure"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5589-3622","authenticated-orcid":false,"given":"Hans","family":"Ehrencrona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1883-1924","authenticated-orcid":false,"given":"Anna","family":"\u00d6fverholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2218-6881","authenticated-orcid":false,"given":"Carolina","family":"Hawranek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovisa","family":"Lovmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Wennstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbro","family":"Hellquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2441-2395","authenticated-orcid":false,"given":"Anna","family":"Ros\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"1922_CR1","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jama.2019.8430","volume":"322","author":"HD Nelson","year":"2019","unstructured":"Nelson HD, Pappas M, Cantor A, Haney E, Holmes R. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;322:666\u201385.","journal-title":"JAMA"},{"key":"1922_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/gutjnl-2019-319915","volume":"69","author":"KJ Monahan","year":"2020","unstructured":"Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE, et al. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)\/Association of Coloproctology of Great Britain and Ireland (ACPGBI)\/United Kingdom Cancer Genetics Group (UKCGG). Gut. 2020;69:411\u201344.","journal-title":"Gut"},{"key":"1922_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1056\/NEJMoa052627","volume":"354","author":"KM Schmeler","year":"2006","unstructured":"Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med. 2006;354:261\u20139.","journal-title":"N Engl J Med"},{"key":"1922_CR4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/eurpub\/ckae093","volume":"34","author":"JM McCrary","year":"2024","unstructured":"McCrary JM, Van Valckenborgh E, Poirel HA, de Putter R, van Rooij J, Horgan D, et al. Genetic counselling legislation and practice in cancer in EU Member States. Eur J Public Health. 2024;34:666\u201375.","journal-title":"Eur J Public Health"},{"key":"1922_CR5","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1200\/JCO.22.00303","volume":"40","author":"MK Frey","year":"2022","unstructured":"Frey MK, Ahsan MD, Bergeron H, Lin J, Li X, Fowlkes RK, et al. Cascade testing for hereditary cancer syndromes: Should we move toward direct relative contact? A systematic review and meta-analysis. J Clin Oncol. 2022;40:4129\u201343.","journal-title":"J Clin Oncol"},{"key":"1922_CR6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/GRF.0000000000000895","volume":"67","author":"MD Ahsan","year":"2024","unstructured":"Ahsan MD, Chandler IR, Min S, Grant B, Primiano M, Greenwald J, et al. Uptake of cascade genetic testing for hereditary breast and ovarian cancer: a systematic review and meta-analysis. Clin Obstet Gynecol. 2024;67:702\u201310.","journal-title":"Clin Obstet Gynecol"},{"key":"1922_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41431-022-01200-z","volume":"31","author":"AL Young","year":"2023","unstructured":"Young AL, Imran A, Spoelma MJ, Williams R, Tucker KM, Halliday J, et al. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review. Eur J Hum Genet. 2023;31:18\u201334.","journal-title":"Eur J Hum Genet"},{"key":"1922_CR8","doi-asserted-by":"crossref","unstructured":"Ahsan MD, Levi SR, Webster EM, Bergeron H, Lin J, Narayan P, et al. Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis. PEC Innov. 2023;2:100138.","DOI":"10.1016\/j.pecinn.2023.100138"},{"key":"1922_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2024.108319","volume":"126","author":"C Hawranek","year":"2024","unstructured":"Hawranek C, Rosen A, Hajdarevic S. How hereditary cancer risk disclosure to relatives is handled in practice\u2014patient perspectives from a Swedish cancer genetics clinic. Patient Educ Couns. 2024;126:108319.","journal-title":"Patient Educ Couns"},{"key":"1922_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10689-024-00373-4","volume":"23","author":"R Levine","year":"2024","unstructured":"Levine R, Kahn RM, Perez L, Brewer J, Ratner S, Li X, et al. Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs. Fam Cancer. 2024;23:111\u201320.","journal-title":"Fam Cancer"},{"key":"1922_CR11","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1038\/s41431-020-00725-5","volume":"28","author":"S Srinivasan","year":"2020","unstructured":"Srinivasan S, Won NY, Dotson WD, Wright ST, Roberts MC. Barriers and facilitators for cascade testing in genetic conditions: a systematic review. Eur J Hum Genet. 2020;28:1631\u201344.","journal-title":"Eur J Hum Genet"},{"key":"1922_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41431-021-00890-1","volume":"30","author":"KS Finn","year":"2022","unstructured":"Finn KS, Pacyna J, Azevedo Tsou C, Jewel Samadder N, Sharp R. Patient-reported anticipated barriers and benefits to sharing cancer genetic risk information with family members. Eur J Hum Genet. 2022;30:53\u201361.","journal-title":"Eur J Hum Genet"},{"key":"1922_CR13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10689-010-9380-3","volume":"9","author":"M Wiseman","year":"2010","unstructured":"Wiseman M, Dancyger C, Michie S. Communicating genetic risk information within families: a review. Fam Cancer. 2010;9:691\u2013703.","journal-title":"Fam Cancer"},{"key":"1922_CR14","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/pon.5142","volume":"28","author":"N Alegre","year":"2019","unstructured":"Alegre N, Perre PV, Bignon YJ, Michel A, Galibert V, Mophawe O, et al. Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1\/2 or MMR gene mutations. Psycho-oncology. 2019;28:1679\u201386.","journal-title":"Psycho-oncology"},{"key":"1922_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ejhg.2014.84","volume":"23","author":"C Jacobs","year":"2015","unstructured":"Jacobs C, Dancyger C, Smith JA, Michie S. Accuracy of recall of information about a cancer-predisposing BRCA1\/2 gene mutation among patients and relatives. Eur J Hum Genet. 2015;23:147\u201351.","journal-title":"Eur J Hum Genet"},{"key":"1922_CR16","doi-asserted-by":"crossref","unstructured":"Lindberg LJ, Wadt KAW, Therkildsen C, Petersen HV. National experiences from 30 years of provider-mediated cascade testing in Lynch Syndrome Families\u2014The Danish Model. Cancers. 2024;16:1577.","DOI":"10.3390\/cancers16081577"},{"key":"1922_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/jgc4.1767","volume":"33","author":"FH Menko","year":"2024","unstructured":"Menko FH, van der Velden SL, Griffioen DN, Ait Moha D, Jeanson KN, Hogervorst FBL, et al. Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1\/BRCA2 variant? A family cancer clinic evaluation. J Genet Couns. 2024;33:615\u201322.","journal-title":"J Genet Couns"},{"key":"1922_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/medethics-2018-105212","volume":"45","author":"B Derbez","year":"2019","unstructured":"Derbez B, de Pauw A, Stoppa-Lyonnet D, Galacteros F, de Montgolfier S. Familial disclosure by genetic healthcare professionals: a useful but sparingly used legal provision in France. J Med Ethics. 2019;45:811\u20136.","journal-title":"J Med Ethics"},{"key":"1922_CR19","doi-asserted-by":"crossref","unstructured":"Metelli S, Chaimani A. Challenges in meta-analyses with observational studies. Evid-based Ment Health. 2020;23:83\u20137.","DOI":"10.1136\/ebmental-2019-300129"},{"key":"1922_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07829-5","volume":"24","author":"C Hawranek","year":"2023","unstructured":"Hawranek C, Ehrencrona H, Ofverholm A, Hellquist BN, Rosen A. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study). Trials. 2023;24:810.","journal-title":"Trials"},{"key":"1922_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s41687-021-00331-z","volume":"5","author":"E Ohlsson-Nevo","year":"2021","unstructured":"Ohlsson-Nevo E, Hiyoshi A, Noren P, Moller M, Karlsson J. The Swedish RAND-36: psychometric characteristics and reference data from the Mid-Swed Health Survey. J Patient Rep Outcomes. 2021;5:66.","journal-title":"J Patient Rep Outcomes"},{"key":"1922_CR22","unstructured":"Spielberger CD, Gorsuch RL, Lushene RE. The State-Trait Anxiety Inventory (\u201cSelf-evaluation questionnaire\u201d). Palo Alto, CA: Consulting Psychologist Press; 1970."},{"key":"1922_CR23","doi-asserted-by":"crossref","unstructured":"Custers JAE, Kwakkenbos L, van de Wal M, Prins JB, Thewes B. Re-validation and screening capacity of the 6-item version of the Cancer Worry Scale. Psycho-oncology. 2018;27:2609\u201315.","DOI":"10.1002\/pon.4782"},{"key":"1922_CR24","unstructured":"R Code Team (2024). R: A language and environment for statistical computing. R Foundation for Statistical Computing. https:\/\/www.R-project.org\/."},{"key":"1922_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ygyno.2019.11.005","volume":"156","author":"NE Griffin","year":"2020","unstructured":"Griffin NE, Buchanan TR, Smith SH, Leon AA, Meyer MF, Liu J, et al. Low rates of cascade genetic testing among families with hereditary gynecologic cancer: an opportunity to improve cancer prevention. Gynecol Oncol. 2020;156:140\u20136.","journal-title":"Gynecol Oncol"},{"key":"1922_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41431-021-00993-9","volume":"30","author":"LM van den Heuvel","year":"2022","unstructured":"van den Heuvel LM, Hoedemaekers YM, Baas AF, Baars MJH, van Tintelen JP, Smets EMA, et al. A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial. Eur J Hum Genet. 2022;30:203\u201310.","journal-title":"Eur J Hum Genet"},{"key":"1922_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/GIM.0b013e318164540b","volume":"10","author":"LE Forrest","year":"2008","unstructured":"Forrest LE, Burke J, Bacic S, Amor DJ. Increased genetic counseling support improves communication of genetic information in families. Genetics Med. 2008;10:167\u201372.","journal-title":"Genetics Med"},{"key":"1922_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-022-00758-z","volume":"23","author":"S Belfrage","year":"2022","unstructured":"Belfrage S, Helgesson G, Lynoe N. Trust and digital privacy in healthcare: a cross-sectional descriptive study of trust and attitudes towards uses of electronic health data among the general public in Sweden. BMC Med Ethics. 2022;23:19.","journal-title":"BMC Med Ethics"},{"key":"1922_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/00207152221085571","volume":"63","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, Lee KS. General trust in the health care system and general trust in physicians: a multilevel analysis of 30 countries. Int J Comp Sociol. 2022;63:91\u2013104.","journal-title":"Int J Comp Sociol"},{"key":"1922_CR30","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41431-024-01544-8","volume":"32","author":"C Naas","year":"2024","unstructured":"Naas C, von Salome J, Rosen A. Patients\u2019 perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure. Eur J Hum Genet. 2024;32:448\u201355.","journal-title":"Eur J Hum Genet"},{"key":"1922_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41431-024-01551-9","volume":"32","author":"A Ofverholm","year":"2024","unstructured":"Ofverholm A, Karlsson P, Rosen A. The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer. Eur J Hum Genet. 2024;32:539\u201344.","journal-title":"Eur J Hum Genet"},{"key":"1922_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10689-015-9854-4","volume":"15","author":"E Sermijn","year":"2016","unstructured":"Sermijn E, Delesie L, Deschepper E, Pauwels I, Bonduelle M, Teugels E, et al. The impact of an interventional counselling procedure in families with a BRCA1\/2 gene mutation: efficacy and safety. Fam Cancer. 2016;15:155\u201362.","journal-title":"Fam Cancer"},{"key":"1922_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/jmg.2007.051581","volume":"44","author":"K Aktan-Collan","year":"2007","unstructured":"Aktan-Collan K, Haukkala A, Pylvanainen K, Jarvinen HJ, Aaltonen LA, Peltomaki P, et al. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing. J Med Genet. 2007;44:732\u20138.","journal-title":"J Med Genet"},{"key":"1922_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10689-018-0083-5","volume":"18","author":"HV Petersen","year":"2019","unstructured":"Petersen HV, Frederiksen BL, Lautrup CK, Lindberg LJ, Ladelund S, Nilbert M. Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes. Fam Cancer. 2019;18:43\u201351.","journal-title":"Fam Cancer"},{"key":"1922_CR35","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1136\/medethics-2020-106236","volume":"47","author":"K Grill","year":"2020","unstructured":"Grill K, Rosen A. Healthcare professionals\u2019 responsibility for informing relatives at risk of hereditary disease. J Med Ethics. 2020;47:e12.","journal-title":"J Med Ethics"},{"key":"1922_CR36","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00439-021-02401-0","volume":"141","author":"A Lucassen","year":"2022","unstructured":"Lucassen A, Clarke A. In the family: access to, and communication of, familial information in clinical practice. Hum Genet. 2022;141:1053\u20138.","journal-title":"Hum Genet"},{"key":"1922_CR37","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(19)32941-1","volume":"394","author":"A Middleton","year":"2019","unstructured":"Middleton A, Milne R, Robarts L, Roberts J, Patch C. Should doctors have a legal duty to warn relatives of their genetic risks?. Lancet. 2019;394:2133\u20135.","journal-title":"Lancet"},{"key":"1922_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14636778.2021.2007065","volume":"41","author":"DR Gordon","year":"2022","unstructured":"Gordon DR, Koenig BA. \u201cIf relatives inherited the gene, they should inherit the data.\u201d Bringing the family into the room where bioethics happens. New Genet Soc. 2022;41:23\u201346.","journal-title":"New Genet Soc"},{"key":"1922_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/15265161.2020.1754505","volume":"20","author":"BM Knoppers","year":"2020","unstructured":"Knoppers BM, Kekesi-Lafrance K. The genetic family as patient?. Am J Bioeth. 2020;20:77\u201380.","journal-title":"Am J Bioeth"},{"key":"1922_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/medethics-2015-102781","volume":"42","author":"S Dheensa","year":"2016","unstructured":"Dheensa S, Fenwick A, Lucassen A. \u2018Is this knowledge mine and nobody else\u2019s? I don\u2019t feel that.\u2019 Patient views about consent, confidentiality and information-sharing in genetic medicine. J Med Ethics. 2016;42:174\u20139.","journal-title":"J Med Ethics"},{"key":"1922_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41431-023-01325-9","volume":"31","author":"K Lyle","year":"2023","unstructured":"Lyle K, Weller S, Horton R, Lucassen A. Immortal data: a qualitative exploration of patients\u2019 understandings of genomic data. Eur J Hum Genet. 2023;31:681\u20136.","journal-title":"Eur J Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01922-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01922-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01922-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T09:25:48Z","timestamp":1759137948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01922-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1922"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01922-w","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Swedish National Ethical Review Board (2019-02647, with amendments 2020-01176, 2021-00718, and 2021-05890). All participants received oral and written information and signed a written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}